Status:
RECRUITING
Cardiac Amyloidosis Registry of University Hospital Leipzig
Lead Sponsor:
University of Leipzig
Conditions:
Cardiac Amyloidosis
Eligibility:
All Genders
Brief Summary
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptom...
Detailed Description
Cardiac amyloidosis is increasingly diagnosed since awareness of the disease and therapeutic options increase. There is evidence from clinical trials about warning signs ("red flags"), diagnostic algo...
Eligibility Criteria
Inclusion
- Confirmed cardiac amyloidosis according to current standards
Exclusion
- refusal to participate
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2033
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06129656
Start Date
May 1 2023
End Date
May 1 2033
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Leipzig
Leipzig, Saxony, Germany, 04103